The Effect of Mental Fatigue on Lower Limb Functional Performance Tests and Brain Activity in a Healthy Population

July 18, 2019 updated by: Romain Meeusen, Vrije Universiteit Brussel

The Influence of Acute Mental Fatigue on Functional Performance Tests of the Lower Limb and Brain Activity in a Healthy Population

Objective of the study

The main objectives of this project are:

  1. To assess the influence of mental fatigue on a return-to-play test battery in healthy population
  2. To assess the influence of mental fatigue on brain functioning during a balance and reaction time task in healthy population In a later stage, these experiments could be carried out in a clinical context (e.g. in an ankle sprain population).

The researchers will use a randomized, placebo controlled, counter-balanced, cross-over design.

Thirteen healthy subjects will visit the lab 3 times. On the first visit (familiarisation trial), the investigators will collect the participants' characteristics. The participants will also be familiarized to the procedures and materials of the experiment during this first visit. The second and third visit contain the experimental setup and will proceed as follows: first, the participants will fill in a mental fatigue scale (M-VAS) and motivation scale. Next, the subjects will carry out a functional test battery (hop test, vertical jump test, Y-balance test, and a balance reaction-time test). Session rate of perceived exertion (RPE) is measured to indicate how fatigued the participants feel because of the test battery; also, M-VAS is collected once more. Then, a short cognitive task (Flanker task) is followed by either a long intensive cognitive task (90 minutes Stroop task) or control task (90 minutes documentary). Afterwards, participants have to carry out the Flanker task, fill in M-VAS (2x), perform the same test battery, fill in session RPE and one final fatigue scale (Nasa TLX). Heart frequency and EEG will be measured continuously during the trials.

Study Overview

Study Type

Interventional

Enrollment (Actual)

13

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Brussels, Belgium, 1050
        • Vrije Universiteit Brussel

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 35 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Healthy (No neurological/cardiorespiratory/psychological disorders)
  • Male and female
  • No medication
  • Non-smoker
  • Between 18 and 35 years old

Exclusion Criteria:

  • Back and/or lower extremity injuries during the past 6 months
  • Bone/joint abnormalities
  • Dizziness, history of loss of consciousness, any inner ear disorders
  • Nervous system disorders or dysfunctions
  • Uncorrected eye disorders/dysfunctions
  • Illness
  • Use of medication or any kind of drugs
  • Use of alcohol, caffeine and heavy efforts 24 hours before each trial
  • Not eating the same meal the night before and the morning of each trial

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Mental Fatigue Condition
modified stroop task
Placebo Comparator: Control Condition
documentary

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Single-leg hop test
Time Frame: Change in single-leg hop test for distance performance: from baseline and 120 minutes after baseline (immediately after the flanker task)
Single-leg hop test for distance performance
Change in single-leg hop test for distance performance: from baseline and 120 minutes after baseline (immediately after the flanker task)
Vertical jump test
Time Frame: Change in vertical jump height performance: from baseline and 120 minutes after baseline (immediately after the flanker task)
Vertical jump height performance
Change in vertical jump height performance: from baseline and 120 minutes after baseline (immediately after the flanker task)
Y-balance test
Time Frame: Change in Y-balance performance: from baseline and 120 minutes after baseline (immediately after the flanker task)
Balance and reach performance; participants have to maintain their balance while reaching as far as possible along 3 different directions.
Change in Y-balance performance: from baseline and 120 minutes after baseline (immediately after the flanker task)
Balance-reaction time test
Time Frame: Change in balance and reaction time performance: from baseline and 120 minutes after baseline (immediately after the flanker task)
Balance and reaction time performance; participants have to maintain their balance while reacting as fast as possible in 3 different directions.
Change in balance and reaction time performance: from baseline and 120 minutes after baseline (immediately after the flanker task)
EEG power spectrum analysis
Time Frame: Change in EEG power spectrum: from baseline and 120 minutes after baseline (immediately after the flanker task)
Brain activity during the Y-balance test, balance-reaction time test and flanker task will be registered at baseline and immediately after the flanker task
Change in EEG power spectrum: from baseline and 120 minutes after baseline (immediately after the flanker task)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mental fatigue Visual Analogue Scale (M-VAS)
Time Frame: Change in M-VAS: at baseline, 20 min after baseline (immediately after the first test battery), 120 min after baseline (immediately after the second flanker task) and 135 min after baseline (immediately after the final test battery)
Subjective measure of mental fatigue (0-10cm; 0 = no mental fatigue; 10 = maximal mental fatigue)
Change in M-VAS: at baseline, 20 min after baseline (immediately after the first test battery), 120 min after baseline (immediately after the second flanker task) and 135 min after baseline (immediately after the final test battery)
Flanker task
Time Frame: Change in flanker task: at baseline and 90 minutes after baseline (immediately after the mental fatiguing task)
Objective measure of mental fatigue; reaction time and accuracy give an objective indication of mental fatigue
Change in flanker task: at baseline and 90 minutes after baseline (immediately after the mental fatiguing task)
90-minute stroop task
Time Frame: Change in reaction time and accuracy will be assessed with a 90-min cognitive task; Reaction Time and Accuracy during the 90-min task will be reported as mean reaction time and accuracy during 8 blocks of 11min15sec
90 minutes mental fatiguing task; reaction time and accuracy give an objective indication of mental fatigue
Change in reaction time and accuracy will be assessed with a 90-min cognitive task; Reaction Time and Accuracy during the 90-min task will be reported as mean reaction time and accuracy during 8 blocks of 11min15sec

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 19, 2018

Primary Completion (Actual)

July 16, 2019

Study Completion (Actual)

July 17, 2019

Study Registration Dates

First Submitted

August 8, 2018

First Submitted That Met QC Criteria

August 20, 2018

First Posted (Actual)

August 22, 2018

Study Record Updates

Last Update Posted (Actual)

July 19, 2019

Last Update Submitted That Met QC Criteria

July 18, 2019

Last Verified

July 1, 2019

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 143201836625

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

IPD Plan Description

individual patient data will not be shared

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Mental Fatigue

Clinical Trials on Mental Fatigue

3
Subscribe